Skip to main content
Clinical Trials/NCT05987969
NCT05987969
Completed
Not Applicable

Efficacy, Tolerability and Safety of a Smartphone-delivered, Fully Automatic Cognitive Behavioural Therapy Programme for Social Anxiety

Aya Technologies Limited1 site in 1 country250 target enrollmentMarch 20, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Social Anxiety Disorder (Social Phobia)
Sponsor
Aya Technologies Limited
Enrollment
250
Locations
1
Primary Endpoint
Change in Social Phobia Inventory (SPIN)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The present study is a randomised controlled trial that seeks to investigate the efficacy and safety of the Alena app as a treatment for social anxiety disorder.

Detailed Description

This will be a 10-week web-based parallel-group unblinded randomised controlled trial with an 8-week intervention period and a 2-week follow-up post-intervention. Participants will be randomly allocated to receive access to the Alena app or to a wait list control group, in a 1:1 ratio. The Alena app primarily comprises CBT-based therapy for social anxiety based on the Clark and Wells model, as well as cognitive assessments, calming exercises and a community forum.

Registry
clinicaltrials.gov
Start Date
March 20, 2023
End Date
June 7, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Aya Technologies Limited
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in Social Phobia Inventory (SPIN)

Time Frame: Change from baseline SPIN at 8 weeks

The SPIN was designed to assess the full spectrum of symptoms that characterise social anxiety, including fear, avoidance and physiological components.

Change in Work and Social Adjustment Scale (WSAS)

Time Frame: Change from baseline WSAS at 8 weeks

The WSAS measures the extent to which the respondent's problem impairs their ability to carry out day-to-day activities, such as work, home management and social leisure activities.

Secondary Outcomes

  • Change in Social Phobia Inventory (SPIN)(Change from SPIN level at the end of the intervention period at 4 weeks later)
  • Work and Social Adjustment Scale (WSAS)(At the follow-up point of 4 weeks after the end of the intervention period.)
  • Serious adverse events(Within the intervention period of 8 weeks)

Study Sites (1)

Loading locations...

Similar Trials